ZG006
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for ZG006, covering 2024-12-16 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer [Phase 1]